BIOA
BioAge Labs·NASDAQ
--
--(--)
--
--(--)
5.16 / 10
Netural
Fund flow metrics score 7.54/10, highlighting robust capital movement with positive Small, Medium, and Large trends, despite some overall and Extra-large inflow challenges. Analyst sentiment is overwhelmingly bullish (100% Buy rating from Piper Sandler), contributing to a constructive but still neutral overall outlook.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-27
InstitutionPiper Sandler
Times predicted1
Historical Win Rate100.0%
What is the market sentiment for BIOA?
- BIOA holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.16/10 (Netural).
